Read more: To view or add a comment, sign in Eli Lilly and Companys (NYSE: $LLY) oral GLP-1 drug orforglipron showed strong Phase 3 results, cutting blood sugar and weight in type 2 diabetes patients
However, not all compounding pharmacies are held to the same standards
Weight Loss Labeling Notice that each active ingredient has two brand names : One for diabetes (Ozempic, Mounjaro, Trulicity) One for weight management (Wegovy, Zepbound, Saxenda) This is purely a marketing distinction, the drugs work the same way
Mild appetite suppression is noticeable but not overwhelming
The frequency peaks during the first 4 weeks of therapy and during dose escalation, when your body undergoes the largest metabolic shifts
10.1007/s00210-020-01910-5 Naunyn-Schmiedebergs Arch Pharmacol